News In blink-and-miss-it moment, Harris vows to expand OOP cap The US Presidential debate barely mentioned pharma topics, but Harris did have one notable sound bite toward the very end of the night.
Oncology Hernexeos and what’s next, with Vicky Brown At Reuters Pharma USA this week, Boehringer Ingelheim's Vicky Brown spoke with us about the company's recent approval for Hernexeos in NSCLC.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.